HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Pietro Palatini Selected Research

glycinexylidide (GX)

12/2006Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
1/2004Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function.
1/2003Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Pietro Palatini Research Topics

Disease

8Liver Diseases (Liver Disease)
10/2014 - 06/2002
6Liver Cirrhosis (Hepatic Cirrhosis)
10/2014 - 06/2002
5Fibrosis (Cirrhosis)
10/2014 - 01/2003
2Neoplasms (Cancer)
07/2003 - 01/2002
1Hepatic Insufficiency
10/2014
1Heart Failure
03/2010
1Chronic Kidney Failure (Chronic Renal Failure)
12/2006
1Renal Insufficiency (Renal Failure)
12/2006
1Fever (Fevers)
07/2003
1Sarcoma (Soft Tissue Sarcoma)
07/2003
1Melanoma (Melanoma, Malignant)
07/2003
1Wounds and Injuries (Trauma)
06/2003
1Hepatocellular Carcinoma (Hepatoma)
05/2003
1Carcinoma (Carcinomatosis)
01/2002

Drug/Important Bio-Agent (IBA)

4Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
10/2014 - 01/2003
4Lidocaine (Xylocaine)FDA LinkGeneric
12/2006 - 01/2003
3EnzymesIBA
10/2014 - 01/2008
3Cytochrome P-450 CYP1A2 (CYP1A2)IBA
01/2013 - 05/2006
3monoethylglycinexylidide (L 86)IBA
12/2006 - 01/2003
3glycinexylidide (GX)IBA
12/2006 - 01/2003
2Fluvoxamine (Luvox)FDA LinkGeneric
03/2010 - 05/2006
2CreatinineIBA
12/2006 - 06/2002
1Protein Isoforms (Isoforms)IBA
10/2014
1Cytochrome P-450 CYP3AIBA
10/2014
1Messenger RNA (mRNA)IBA
10/2014
1pregnane X receptorIBA
10/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2014
1Carbon Tetrachloride (Tetrachloromethane)IBA
10/2014
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2013
1Benzo(a)pyreneIBA
01/2013
1Carrier Proteins (Binding Protein)IBA
10/2010
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
05/2006
13-methylxanthineIBA
05/2006
11-methyluric acidIBA
05/2006
1Theophylline (Theon)FDA LinkGeneric
05/2006
11,3-dimethyluric acidIBA
05/2006
1Liposomes (Liposome)IBA
07/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2003
1Sodium Chloride (Saline Solution)FDA LinkGeneric
07/2003
1Hypotonic SolutionsIBA
07/2003
1benzoquinone (quinone)IBA
05/2003
1NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA
05/2003
1NAD (NADH)IBA
05/2003
1Erythromycin (Erycette)FDA LinkGeneric
01/2003
1Cystatin CIBA
06/2002
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2002
1Cisplatin (Platino)FDA LinkGeneric
01/2002

Therapy/Procedure

2Drug Therapy (Chemotherapy)
07/2003 - 01/2002
1Renal Dialysis (Hemodialysis)
12/2006
1Intravenous Injections
12/2006
1Parenteral Infusions
07/2003
1Surgical Instruments (Clip)
06/2003
1Local Anesthesia
06/2003
1Combined Modality Therapy
01/2002